Codexis, a Shell Oil-backed developer of biocatalysts for biofuel and pharma applications, raised $78 million on Wednesday by offering 6.0 million shares at $13.00, the low end of the proposed $13 to $15 range. Codexis plans to list on the NASDAQ under the symbol CDXS. Credit Suisse acted as lead manager on the deal.
